Genetic mutations of butyrylcholine esterase identified from phenotypic abnormalities in Japan.
We have identified 12 kinds of genetic mutations of butyrylcholine esterase (BCHE) from phenotypic abnormalities, showing that BCHE activities were deficient or diminished in sera. These genetic mutations, detected by PCR-single-strand conformation polymorphism analysis and direct sequencing, consisted of one deletion (BCHE*FS4), nine missense (BCHE*24 M, *1005, *250P, *267R, *330I, *365R, *418S, *515C, *539T), and two nonsense mutations (BCHE*119STOP, *465STOP). All of the individuals deficient in serum BCHE activity were homozygous for silent genes (6 of 6). Fifty-eight percent of the individuals (31 of 53) with slightly reduced serum BCHE activity were heterozygous for silent genes. They also showed a higher frequency (47% as allele frequency) of the K-variant than the general population (17.5%). Finally, we confirmed low serum BCHE activity in 10 of 23 individuals heterozygous for silent genes.
Maekawa
M
M
Clinical Laboratory, National Cancer Center Hospital, Tokyo, Japan. mmaekawa@gan2.ncc.go.jp
Sudo
K
K
Dey
D C
DC
Ishikawa
J
J
Izumi
M
M
Kotani
K
K
Kanno
T
T
D002091:Butyrylcholinesterase / Q000097:blood / Q000235:genetics*; D005838:Genotype; D006579:Heterozygote; D006720:Homozygote; D006801:Humans; D007206:Individuality; D007564:Japan; D009154:Mutation; D010641:Phenotype; D016133:Polymerase Chain Reaction; D018807:Polymorphism, Single-Stranded Conformational; D012016:Reference Values; D012709:Serum Albumin / Q000378:metabolism
D012709:Serum Albumin; D002091:Butyrylcholinesterase